Effects of High Altitude on AMPK Activation
Effects of High Altitude on 5' Adenosine Monophosphate-activated Protein Kinase (AMPK) Activation and Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Regulation
Sponsor: University of Colorado, Denver
This observational or N/A phase trial investigates IUGR and Preeclampsia and is currently actively recruiting participants. University of Colorado, Denver leads this study, which shows 18 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
18 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Sep 2024 — Feb 2026 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Dec 2023 [monthly]
Recruiting
▶ Show 13 earlier versions
-
Dec 2021 — Sep 2022 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jul 2020 — Nov 2020 [monthly]
Recruiting
-
Jun 2019 — Jul 2020 [monthly]
Recruiting
-
Jan 2019 — Jun 2019 [monthly]
Recruiting
-
Oct 2018 — Jan 2019 [monthly]
Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Colorado, Denver
For direct contact, visit the study record on ClinicalTrials.gov .